Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors

Jaffer A. Ajani, Jeannelyn S. Estrella, Qiongrong Chen, Arlene M. Correa, Lang Ma, Ailing W. Scott, Jiankang Jin, Bin Liu, Min Xie, Kazuki Sudo, Hironori Shiozaki, Brian Badgwell, Brian Weston, Jeffrey H. Lee, Manoop S. Bhutani, Hisashi Onodera, Koyu Suzuki, Akihiro Suzuki, Sheng Ding, Wayne L. HofstetterRandy L. Johnson, Robert S. Bresalier, Shumei Song

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences